SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950133-98-002700
Filing Date
1998-07-23
Accepted
1998-07-23 00:00:00
Documents
7
Group Members
BB BIOTECH AGBIOTECH FOCUS S.A.BIOTECH GROWTH S.A.BIOTECH INVEST S.A.BIOTECH TARGET S.A.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D RE: BIOCHEM PHARMA, INC. SC 13D 49712
2 TRANSLATION OF JUNE 21, 1995, MINUTES EX-99.4 4158
3 TRANSLATION OF JUNE 24, 1996, MINUTES EX-99.5 4472
4 TRANSLATION OF JUNE 21, 1995, MINUTES EX-99.6 4522
5 TRANSLATION OF THE JANUARY 3, 1997, MINUTES EX-99.7 4310
6 TRANSLATION OF JANUARY 3, 1997, MINUTES EX-99.8 4308
7 JOINT FILING AGREEMENT EX-99.9 3256
  Complete submission text file 0000950133-98-002700.txt   77584
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Subject) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 0131
Type: SC 13D | Act: 34 | File No.: 005-45089 | Film No.: 98670434
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000